PWG
BIIB icon

Portside Wealth Group’s Biogen BIIB Stock Holding History

Portside Wealth Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,848
Closed -$552K – 423
2024
Q3 		$552K Buy
2,848
+51
+2% +$10.7K 0.09% 212
2024
Q2 		$648K Sell
2,797
-20
-0.7% -$4.35K 0.12% 174
2024
Q1 		$607K Sell
2,817
-245
-8% -$57.4K 0.11% 190
2023
Q4 		$792K Sell
3,062
-522
-15% -$128K 0.15% 151
2023
Q3 		$925K Buy
3,584
+42
+1% +$11.2K 0.17% 125
2023
Q2 		$1.01M Buy
+3,542
New +$1.05M 0.19% 124

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Portside Wealth Group's BIIB Position: Q4 2024 in Review

Portside Wealth Group sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,848 shares — an estimated $552K sold.

Portside Wealth Group first reported a position in BIIB in Q2 2023 and held it in 6 quarters. The position peaked at $1.01M in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Portside Wealth Group reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Portside Wealth Group sold 2,848 Biogen shares in Q4 2024, an estimated $552K.
  • Portside Wealth Group first reported a position in Biogen in Q2 2023 and held it in 6 quarters.
  • Portside Wealth Group's Biogen position peaked at $1.01M in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Portside Wealth Group's 13F filing for Q4 2024, filed 15 Jan 2025.